Co-treatment with azelinidipine and olmesartan inhibits advanced glycation end products (AGEs) elicited down-regulation of adiponectin mRNA levels in cultured adipocytes partly via its anti-oxidative property - Maeda, S; Matsui, T; Takeuchi, M; Yamagishi, S (Int J Cardiol, 2011)